Stockholders' Equity - Summary of Shareholders Equity Warrants Outstanding (Details) - Warrants [Member] - shares |
3 Months Ended | 12 Months Ended | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2020 |
Dec. 31, 2019 |
|||||||||
Stock Holders Equity [Line Items] | ||||||||||
Shares Outstanding, beginning | 5,397 | [1] | 5,799 | |||||||
Shares Issued | ||||||||||
Shares Exercised | (1,606) | [2] | (402) | |||||||
Shares Tendered | ||||||||||
Shares Expired | (420) | |||||||||
Shares Outstanding, ending | 3,371 | [3] | 5,397 | [1] | ||||||
|
X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non option equity instruments tendered. No definition available.
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements for which rights to exercise lapsed. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|